Introduction
Amyloidosis is usually not diagnosed until clinical symptoms have become apparent and the disease has progressed to the point of irreversible organ damage (3,ll). Early and especially preclinical diagnosis would therefore be most desirable for early treatment to prevent the deposition of larger amyloid masses and thus to delay or even prevent the onset of symptoms and consequently improve the prognosis.
Direct demonstration of the presence of amyloid and its chemical classification are dependent on examination of tissues (3,ll). After amyloid has been identified by Congo Red staining (23) it can be chemically classified via amino acid sequence studies (1,11), son of Labs 1-3 revealed amyloid in 12 rectal and 18 r e d biopsies d u a t e d by Lab 3, whereas Lab 2 missed amyloid in two of 18 renal biopsies and Lab 1 missed amyloid in 11 of 12 rectal biopsies. Most amyloid was missed when only minute amounts of amyloid were m t . Had our tcchaique (Lab 3) been available at the time of biopsy, amyloid could have been d i a g n d years earlier, thctcby spadng the patient further biopsies and allowing initiation of d e r treatment before organ damage could OCCUT. ( J Histoahun C~~o c h~n 43: [863] [864] [865] [866] [867] [868] [869] 1995) by immunochemistry (16,27), via immunohistochemistry on paraffin (4,8,18,21), or on semi-thin and plastic ultra-thin sections (6,19). Indirect tagging of amyloid in vivo has also been performed by radioactive imaging using the amyloid-P component (13.14) or ~2-microglobulin (7). Thus far, identification of minute amyloid deposits has not been established in routine laboratories.
This study, which was carried out on a series of patients with inflammatory diseases, was stimulated by the disturbing findings by us and others (12,13,15) of a discrepancy between clinical symptoms that were indicative of amyloidosis and lack of pathological confirmation, particularly in primary biopsies performed during early amyloidosis.
The question that therefore arose was whether or not amyloid could already be found in the primary biopsies that regularly had been recorded as being negative for amyloid in patients who later developed generalized amyloidosis. To answer this question, we applied the combination of Congo Red staining and immunohistochemistry using monoclonal antibodies (MAbs) on 57 consecutive biopsies available from 42 patients with renal problems associated with various rheumatic and related pediatric inflammatory diseases. We reexamined these biopsies and compared our results with those documented in the patients' charts. In addition, 14 rectal biopsies were performed in 9/42 patients with suspected amyloidosis. Ten of these biopsies were performed before renal biopsy and two of them were performed after the renal biopsy had been read as negative. Finally, two rectal biopsies were performed as follow-up biopsies.
Diagnosis of Amyloidia Different Laboratories. Immediately after biopsy, all specimens were fixed in 10% buffered formalin (4% formaldehyde) and investigated on approximately 4-6-wm thick paraffin sections. The investigations were performed by independent laboratories designated as laboratories (labs) 1, 2, and 3.
For Laboratory 1 (Lab 1). four different unspecialized laboratories and institutes of pathology were combined in this category. They evaluated recd biopsy specimens using only an unspecified Congo Red staining method at the time at which the biopsy had been taken.
For Laboratory 2 (Lab 2). specialized examination was performed in a single institute of pathology of all renal specimens at the time of biopsy using the alkaline Congo Red staining method with inspection underpolarized light (23) and, in unclear cases, additional electron microscopy according to standard protocols For Laboratory 3 (Lab 3), retrospective examination in a specialized lab was performed on all 57 rectal and renal biopsies using the alkaline Congo Red staining method (23) without any knowledge of preceding results (blinded fashion). Reexamination of all results was performed on serial sections cut from the original blocks which had served for diagnosing amyloid in Labs 1 and 2. Additional immunohistochemical diagnosis was performed on adjacent paaffin smions using the AA-specific MAb mcl(l7) (Dakopam, Code No. M 759; Glostrup, Denmark) as the first antibody and the unlabeled immunoperoxidase technique as the staining system using the antiperoxidase MAb mclOO (17). In cases of discrepancy, the same section was examined once again. In cases where discrepancies remained, additional sections were prepared and examined in the same way using Congo Red and immunohistochemistry. In patients 3, 5 . and 16, 8-to 9-year-old mounted and stained tissue sections were additionally investigated after removal of the coverslip in xylol, followed by alcohol in decreasing concentrations and finally by rehydration in PBS.
Classificltion of Amyloid. Amyloid was immunohistochemically classified using a panel of antibodies directed against all known major amyloid classes including amyloid-A (17). amyloid of immunoglobulin I-light chain origin, amyloid of K-light chain origin, amyloid of transthyretin origin, and amyloid of P2-microglobulin origin, including the appropriate controls as described in detail previously (17,18,20,22).
High-&tiviq D i a g n k of Amyloid (Lab 3). In cases where no amyloid was found, approximately 10 additional tissue sections were examined. A11 sections, particularly those with tiny amyloid deposits, were examined by immunohistochemistry and subsequently investigated by Congo Red using three different techniques. The first technique verified the immunohistochemically stained areas as amyloid with Congo Red on adjacent sections (51 biopsies). The second technique used pre-staining of the slides with Congo Red, followed by immunohistochemistry (nine slides). In this case, evety immunohistochcmically muked uea was subsequently d uated in polarized light. A third technique applied immunohistochemistry first. The stained areas were identified and carefully documented, the sections destained in 80% acetic acid for 2 min (18). subsequently restained with Congo Red, and the formerly stained areas compared with those now stained with Congo Red (five slide).
The first technique was used when amyloid deposits could easily be traced into adjacent sections. The latter two techniques were primarily applied to biopsies with very few, minute spots of amyloid, which could hardly ~_ _ ~ be traced into adjacent sections, and in all discordant and negative cases. The third technique was particularly applied when the immunohistochemical coloration applied in the second technique was so intense that it obscured the Congo Red staining beneath. In several instances, more than one of these techniques was applied to the same biopsy. Finally, all techniques were suitable to solve some of the problems and yielded clear results.
Early and Late Biopsies. The 32 biopsies were subdivided into "early" and "late" biopsies, as shown in 'lible 1. Amyloid was designated as "early" when no or small amounts (+) of amyloid were present in the primary biopsy (Table 1; Figure 1 ). It was designated as "late" when the biopsy had moderate (+ + ) or large (+ + + ) amounts of amyloid or when the biopsy had been taken at least 1 year after the primary biopsy.
Results

Identzj5cation of Amyloid
The diagnosis of amyloid according to Puchtler et al. (23) is illustrated in Figure 1 . Amyloid is shown after Congo Red staining (Figure la) and in polarized light ( Figure Ib) (3,ll) . In an adjacent section, the same deposits are immunohistochemically stained using the MAb mcl ( Figure IC) . Moderate or massive amyloid deposits, as shown in Figure 1 , were recognized as such by all investigators (concordant results). Small amyloid deposits, however, could be missed depending on the technique used. Minute amounts of amyloid were frequently missed in rectal biopsies by Lab 1 (see below) and also in renal biopsies by Lab 2. An example of the latter is shown in Figures 2 and 3 .
Of the 57 biopsies (14 rectal and 43 renal), 32 biopsies from 17 patients (30 of which contained amyloid) were examined further by Lab 3. Of these 17 patients, seven were found to have amyloid in their first biopsy and no further biopsy was required. Of the remaining 10 patients, nine had additional biopsies because the primary biopsy had been read as negative for amyloid by Lab 1 or Lab 2. Two additional biopsies were taken only in patient 14 ('liable 1) during a 3-year period to control the further development of amyloid deposits that had already been detected in the primary biopsy under therapy. Table 1 presents the clinical data of the 17 patients as well as the amyloid diagnoses made by the three labs.
Immunohistochemical Identzj5cation of the Amyloid Cluss
The immunohistochemical classification of amyloid identified in all 17 patients was only the AA type, since only the anti-AA (mcl) MAb was strongly reactive ( Figure IC) , whereas all other antibodies proven to recognize the other common amyloid types (see Materials and Methods) were unreactive (17, 18, 22) .
Comparison of Results from Dzferent Laboratories
An illustration and comparison of the amyloid diagnosis by the different labs on the 32 biopsies is presented in Figure 4 . The diagnoses of the 14 rectal biopsies made by Lab 1 (as retrieved from the charts) were compared with the data obtained through reexamination by Lab 3. Of the 12 rectal biopsies with amyloid as diagnosed in Lab 3, only one was previously identified by Lab 1. In contrast, of the 18 renal biopsies with amyloid as diagnosed by Lab 3, 16 had been found by Lab 2.
More Misses in Eady Compared with Late Biopsies
To answer the question as to whether early biopsies, which presumably contain less amyloid than late biopsies, are prone to falsenegative results, we subdivided the 14 rectal and the 18 renal biopsies into early (nine rectal and five renal) and late (five rectal and 13 renal) biopsies (see Materials and Methods). As shown in Figure  4 , the results of this subdivision demonstrate that early biopsies are more prone to &-negative results than late biopsies. This statement is obvious, since Lab 1 missed the amyloid in eight early rectal biopsies and in three of five late rectal biopsies, and amyloid was missed in two of five early renal biopsies, but in none of the 13 late renal biopsies. It is also clear from Figure 4 that the renal biopsies were mostly late biopsies because they were usually taken after the rectal biopsies had been falsely read as negative for amyloid. In contrast, in all 13 late renal biopsies the amyloid deposits were correctly diagnosed by Lab 2.
Evaluation of Discordant Results
The reasons for the discordance among the different labs were of particular interest because of diagnostic and therapeutic consequences. By carefully analyzing the slides biopsy by biopsy, we discovered major faults and shortcomings.
Insensitivity of the Method. The major problem was insensitivity of the evaluation process using the Congo Red method. Because all the slides were read blindly, minute amyloid spots remained undetected after Congo Red staining in four biopsies (three rectal, one renal) in the first screening by one of the authors (RPL, Lab 3). All four biopsies were early biopsies. Howewr, amyloid was clearly identifed after immunohistochemistry with Congo Red pte-stahhg (second variant; see Materials and Methods) or immunohistochemical pre-staining and Congo Red after destaining (third variant; see above). This demonstrates that all laboratories are prone to miss early amyloid deposits when no further measures are employed.
Quality of Sections and Staining Method. Another problem may be the quality of the sections. In one original section, the amyloid deposits could not be found microscopically because the section was too thick and was overstained with hemalum, and probably also inadequately stained with Congo Red. New sections from the same tissue block after the appropriate Congo Red staining (23) clearly showed the presence of amyloid, which was subsequently confirmed immunohistochemically.
Sampling Error.
A further problem came to our attention in the second biopsy of patient 8. The Congo Red-stained section clearly showed amyloid, but the immunohistochemically stained section did not show coloration and was read as negative. We therefore performed Congo Red staining and immunohistochemistry on the same section (second and third variant; see Materials and Methods). Only these techniques permitted a definition of what we called sampling error. Figures 3a and 3b demonstrate the discontinuity of amyloid deposits in adjacent sections. 1 3 1 1 1 3 1 2 1 
Immunohistochemical Staining in the Absence of Amyloid
Immunohistochemical staining of intravascular plasma has frequently been seen in patients examined here. This staining, which has not been documented here, can be considered an immunohistochemical counterpart of the acute-phase reaction in patients with severe inflammations. In addition to the staining of plasma, other small extracellular deposits in one biopsy from patient 3 were immunostainable with anti-AA (mcl) MAbs but lacked the green birefringence. These deposits could correspond to those described by Shirahama et al. (25) and Tornroth et al. (26) . who reported AA antigenic proteinaceous deposits lacking amyloid characteristics. These deposits can be considered to be related to amyloid, as either protein deposits preceding amyloid formation or as rem-nants subsequent to the degradation of amyloid or its precursor. The latter possibility, which had been proposed by Tomroth et al. (26) , appears to be more likely, since this biopsy was taken 7.5 years after the first biopsy had shown small amounts of amyloid and the clinical symptoms have resolved during the follow-up.
Discussion
The aim of this study was to solve the known discrepancy between the clinical picture resembling beginning amyloidosis and the inability of the pathologist to detect amyloid in primary biopsies of the respective patients. This also applied to our patients with juvenile rheumatoid arthritis and other pediatric inflammatory diseases.
Here, we demonstrate that we most likely have solved this problem by increasing the sensitivity of the diagnostic method. Applying combinations of Congo Red staining and immunohistochemistry with AA-specific MAbs (17). the sensitivity of the method was increased to such an extent that we now can recognize amyloid which has thus far escaped detection. By choosing a retrospective series of consecutive biopsies from several patients who later developed AA amyloidosis, we turned our attention to the biopsies that had been read as negative for amyloid and that had preceded the positive biopsies. Amyloid was detected in 15 of such negative biopsies, and it is obvious from these studies that the evaluation of the conventional Congo Red staining method employed by routine laboratories had led to missing amyloid in many biopsies. Since the designation of Lab 1 comprises four different pathological institutes not specialized in the diagnosis of amyloid. this may be a common problem not restricted only to these institutes. In fact, unreliability of the evaluation of the conventional Congo Red staining method has been reported not only from Germany but also from England and France (12, 13, 15) .
Because the extent of the missed amyloid deposits was surprising and disturbing to us (over 90% of rectal biopsies), the reasons had to be analyzed. Since one of the authors of this report (RPL) has himself failed to identlfy amyloid in some biopsies during the first blind readings, the missed amyloid cannot be attributed to the inexperience of the investigators alone. Indeed, some of the tiny amyloid deposits had been located only after immunohistochemistry had marked these areas, which then were recognized as amyloid by polarization microscopy. Since the immunohistochemical staining has guided the investigator to some small amyloid deposits, the data on the Congo Red readings by Lab 3, as summarized in Table 1 , are not independent of immunohistochemistry and therefore cannot be expected to be identical to the Congo Red readings reported by Lab 1 and Lab 2.
In addition, tissue sections can also be negative for amyloid owing to sampling error whereby the presence of amyloid within the biopsy may be so sparse that not every tissue section contains amyloid. We recommend that this sampling error should be considered in apparently negative biopsies.
Because renal biopsies were usually taken later in the course of progressive AA amyloidosis, i.e., after one or more rectal biopsies had failed to reveal amyloid, a renal biopsy can therefore be expected to contain more amyloid. This statement is underscored by the fact that the amyloid amount grade + was found in loll2 rectal and 6/18 renal but grade + + + only in 11/18 renal biopsies ( Table 1 ). The early nature of rectal biopsies may in part explain the many misses of amyloid deposits compared with renal biopsies (Figure 4 ) and contradicts the suggestion by some (12) that renal biopsies are preferred as a site for diagnosing amyloid.
This contention that the kidney may be the preferred organ to diagnose amyloid could also have been derived from our data on renal biopsies, since the readings of Lab 2 seemed to be more reliable compared with the data of rectal biopsies (Lab 1). Since the more precise data by Lab 2 could be attributed not only to the larger amount of amyloid in the respective biopsies but also in part to employing electron microscopy in unclear Congo Red readings, the renal biopsy should not be equated with better precision without further analysis of the mentioned criteria.
Compared with the results of Lab 3, Congo Red and electron microscopy (Lab 2) were found to be almost as precise as Congo Red and immunohistochemistry (Lab 3), since this combination failed in only two of the 18 renal biopsies, with the failure only seen in early biopsies (Figure 4) .
The advantages of early high-precision diagnosis of amyloidosis for the patient are the initiation of early therapy and avoidance of the sequelae of further biopsies. A full account of these advantages will be the subject of a forthcoming report by two of the authors (HM, RPL) .
Another important question is whether minute amounts of amyloid which may not be considered pathogenic by the pathologist because of their size may nevertheless be of clinical significance. Our patients who had minute amounts of amyloid in their primary biopsies developed severe, and in three cases (patients 8, 15, and 17; Table 1 ) fatal, AA amyloidosis; only two patients (patients 3 and 14) improved. Therefore, as in the case of early cancers, even the tiniest AA amyloid deposits at any anatomic site must be considered an indication of potentially fatal disease. Consequently, a patient with AA amyloid deposits desperately requires therapeutic intervention, particularly when inflammatory disease activity is present. Owing to the lack of a highly sensitive diagnostic procedure at the time of biopsy, the minute amounts of amyloid in our patients remained undetected and AA amyloidosis could progress to a point where it was detected by conventional evaluation using the Congo Red method. In some cases, however, therapy came too late (see above).
Patients with severe idammatory episodes due to juvenile rheumatoid arthritis are treated by us with methotrexate when milder agents are inefficient. However, when AA amyloid is verified and the inflammation cannot sufficiently be controlled, methotrexate is replaced by chlorambucil (5, 15, 24) .
To alleviate this lack of sensitivity of the conventional evaluation of tissue sections using the Congo Red method, some authors have tried to replace the direct biopsy proof of amyloid with a more indirect method, i.e., radioactive imaging, using the amyloid-P component or b2-microglobulin (7, 13, 14) . These methods have been criticized for not being strictly quantitative with respect to the amount and distribution of amyloid deposited (28). In addition, Gejyo (9) has recently shown that the tracer Pzm may not be deposited within the amyloid but taken up by macrophages adjacent to the amyloid deposits in bzm-derived amyloid deposits. Therefore, the question of whether the methods applying imaging can identify early amyloid has not yet been conclusively answered. The same applies to the fat biopsy, which is used as a screening method to detect amyloidosis (10). In addition, the comparison of this improved Ijiopsy method and the imaging procedures is still ahead of us.
Practical Recommendations
To directly apply what we have learned from this study and from decades of experience with diagnosing and classdying amyloid (6, 17, 19) , the following recommendations are given: (a) use of a stringent Congo Red staining method such as that of Puchtler et al. (21) . including the preparations of tissue sections as recommended by Glenner (11) , since Congo red remains the "gold standard" of amyloid detection (2,3); (b) the diagnosis "biopsy without amyloid" is the most difficult, since it is open to false-negative results, as has been amply documented here, including the grave consequences for the patient. In cases where no amyloid is detected, examination of at least 10 additional tissue sections of an adequate biopsy (submucosa present in rectal and glomeruli and tubules in renal biopsy) is recommended (c) in cases where no amyloid is detected in b and the suspicion of the clinician remains, immunohistochemistry using MAbs (with weak or no counterstaining with hemalum) serves as a screening method for detecting the areas of possible amyloid. The stained areas must then be verified by inspecting Congo Red-stained sections in polarized light, and three different approaches have been applied (see Materials and Methods) .
Control immunohistochemical staining of an already classified amyloid is mandatory; and (d) inspection of Congo Red-stained tissue sections should be performed using a high-quality polatization microscope and maximal microscopic light within a dimmed room. Should no green birefringence be seen with the x 6.3 objective, evaluation at a higher magnification (objective 16 and 40) is mandatory.
